A sensitive radioimmunoassay, combined with solid-phase extraction, for the sub-nanogram per ml determination of ondansetron in human plasma
- 31 March 1994
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 12 (3) , 361-371
- https://doi.org/10.1016/0731-7085(94)90012-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- International Harmonization and Consensus DIA Meeting on Bioavailability and Bioequivalence Testing Requirements and StandardsDrug Information Journal, 1991
- Determination of Ondansetron in Plasma and Its Pharmacokinetics in the Young and ElderlyJournal of Pharmaceutical Sciences, 1991
- Prevention of Postoperative Nausea and Vomiting Using Ondansetron, a New, Selective, 5-HT3 Receptor AntagonistAnesthesia & Analgesia, 1991
- Ondansetron in treatment of schizophreniaThe Lancet, 1991
- Ondansetron: a new antiemetic for patients receiving cisplatin chemotherapy.Journal of Clinical Oncology, 1990
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and VomitingNew England Journal of Medicine, 1990
- Method validation in the bioanalytical laboratoryJournal of Pharmaceutical and Biomedical Analysis, 1990
- PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONISTThe Lancet, 1987
- Automated Extraction of Drugs from Biological FluidsInternational Journal of Environmental Analytical Chemistry, 1984